CD38 contributes to tumor progression and tumor microenvironment reshaping in epithelial ovarian cancer
Elevated CD38 expression is associated with EOC progression, TME remodeling, and immune response modulation. Thus, CD38 could be a promising target for ovarian cancer immunotherapy.
Authors
- Liyun Shan
- Yinping Liu (ORCID: https://orcid.org/0000-0001-5468-2148)
- Wei Wang (ORCID: https://orcid.org/0000-0002-3569-2444)
- Yanli Li (ORCID: https://orcid.org/0000-0002-5722-7375)
- Shengjie Xu (ORCID: https://orcid.org/0009-0004-4537-1048)
- Xiangnan Liu (ORCID: https://orcid.org/0000-0002-0094-8948)
- Yingying Li (ORCID: https://orcid.org/0000-0002-1971-2556)
- Enci Dai
Institutions
- Shanghai Jiao Tong University (CN)
- Shanghai Ninth People's Hospital (CN)
- Shanghai First People's Hospital (CN)
- Shanghai Sixth People's Hospital (CN)
Publication Details
- Journal
- Translational Oncology
- Published
- 2025-05-16
- DOI
- https://doi.org/10.1016/j.tranon.2025.102414
- Citations
- 1
- Primary Topic
- Calcium signaling and nucleotide metabolism
- Type
- article
- Field-Weighted Citation Impact
- 1.12